[1]
Piparva, K.G. et al. 2026. Clinical Outcomes of Parenteral Methylene Blue as Adjunct Therapy in Hospitalized COVID-19 Patients: A Retrospective Cohort Study. National Journal of Medical Research. 16, 04 (Oct. 2026), 289–297. DOI:https://doi.org/10.55489/njmr.160420261407.